Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 245,000 | reported | 24 Feb 2023 | tx 2+960,000 |
| Gritstone Oncology, Inc. | 58,698 | reported | 31 Jan 2022 | tx 5+305,180 |
| ZEVRA THERAPEUTICS, INC. | 48,125 | reported | 11 May 2026 | tx 12+492,499−107,873 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | SALE | ZEVRA THERAPEUTICS, INC. | 1,794 | 11.30 USD | 10b5-1 |
| 30 Jan 2026 | SALE | ZEVRA THERAPEUTICS, INC. | 4,080 | 8.83 USD | |
| 30 Jan 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 11,333 | — | |
| 29 Jan 2026 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 37,500 | 0.00 USD | deriv |
| 29 Jan 2026 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 75,000 | 0.00 USD | deriv |
| 30 Jan 2026 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 11,333 | 0.00 USD | deriv |
| 26 Jun 2025 | SALE | ZEVRA THERAPEUTICS, INC. | 24,000 | 9.21 USD | |
| 21 Jun 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 66,666 | — | |
| 21 Jun 2025 | EXERCISE | ZEVRA THERAPEUTICS, INC. | 66,666 | 0.00 USD | deriv |
| 30 Jan 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 34,000 | 0.00 USD | deriv |
| 30 Jan 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 68,000 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 200,000 | 0.00 USD | deriv |
| 24 Feb 2023 | GRANT_AWARD | Lyell Immunopharma, Inc. | 245,000 | 0.00 USD | deriv |
| 10 Oct 2022 | GRANT_AWARD | Lyell Immunopharma, Inc. | 715,000 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Gritstone Oncology, Inc. | 19,240 | 0.00 USD | |
| 31 Jan 2022 | GRANT_AWARD | Gritstone Oncology, Inc. | 115,440 | 0.00 USD | deriv |
| 07 Jan 2021 | GRANT_AWARD | Gritstone Oncology, Inc. | 25,500 | 0.00 USD | |
| 08 Mar 2021 | GRANT_AWARD | Gritstone Oncology, Inc. | 60,000 | 0.00 USD | deriv |
| 13 May 2020 | GRANT_AWARD | Gritstone Oncology, Inc. | 85,000 | 0.00 USD | deriv |